| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6391860c5580c0c27242cd0ca13be4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_054b01dd5653760a95f14bcae591b265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cc4c98b38d294f5829bc7e18f7dbb19 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-362265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0429 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D61-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3696 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate |
2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e56c71b7ede1385708d5d9defbada9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5eac6d4c314b7f55d3267b33c2598a7 |
| publicationDate |
2011-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011049709-A1 |
| titleOfInvention |
Methods and systems for providing red blood cell products with reduced plasma |
| abstract |
Methods and systems for processing and conditioning red blood cells are disclosed. The methods and systems may be used to make a readily transfusible red blood cell product with reduced plasma. In general, the plasma content of the supernatant of the red blood cell product is no greater than about 15%. The red blood cell products are prepared using the disclosed methods and systems remain transfusible for up to 42 days. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2777393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2777727-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3028724-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6040307-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013043658-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015124236-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013043711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014162435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3351101-A1 |
| priorityDate |
2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |